Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.
J Exp Clin Cancer Res. 2023 Nov 4;42(1):293. doi: 10.1186/s13046-023-02838-3.
J Exp Clin Cancer Res. 2023.
PMID: 37924157
Free PMC article.
Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma.
Timpanaro A, Piccand C, Uldry AC, Bode PK, Dzhumashev D, Sala R, Heller M, Rössler J, Bernasconi M.
Timpanaro A, et al. Among authors: dzhumashev d.
Int J Mol Sci. 2023 Jan 30;24(3):2601. doi: 10.3390/ijms24032601.
Int J Mol Sci. 2023.
PMID: 36768928
Free PMC article.
Item in Clipboard
Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells.
Dzhumashev D, Anton-Joseph S, Morel VJ, Timpanaro A, Bordon G, Piccand C, Aleandri S, Luciani P, Rössler J, Bernasconi M.
Dzhumashev D, et al.
Eur J Pharm Biopharm. 2024 Jan;194:49-61. doi: 10.1016/j.ejpb.2023.11.020. Epub 2023 Nov 27.
Eur J Pharm Biopharm. 2024.
PMID: 38029941
Free article.
Item in Clipboard
Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma.
Alijaj N, Moutel S, Gouveia ZL, Gray M, Roveri M, Dzhumashev D, Weber F, Meier G, Luciani P, Rössler JK, Schäfer BW, Perez F, Bernasconi M.
Alijaj N, et al. Among authors: dzhumashev d.
Cancers (Basel). 2020 Nov 10;12(11):3313. doi: 10.3390/cancers12113313.
Cancers (Basel). 2020.
PMID: 33182650
Free PMC article.
Item in Clipboard
Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma.
Dzhumashev D, Timpanaro A, Ali S, De Micheli AJ, Mamchaoui K, Cascone I, Rössler J, Bernasconi M.
Dzhumashev D, et al.
Cancers (Basel). 2022 Oct 14;14(20):5048. doi: 10.3390/cancers14205048.
Cancers (Basel). 2022.
PMID: 36291832
Free PMC article.
Item in Clipboard
Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V, Zaytseva-Zotova D, Zintchenko A, Levada T, Shilov Y, Andreyev D, Dzhumashev D, Metelkin E, Urusova A, Demin O, McDonnell K, Troiano G, Zale S, Safarovа E.
Shalgunov V, et al. Among authors: dzhumashev d.
J Control Release. 2017 Sep 10;261:31-42. doi: 10.1016/j.jconrel.2017.06.006. Epub 2017 Jun 10.
J Control Release. 2017.
PMID: 28611009
Free article.
Item in Clipboard
Cite
Cite